• Decrease font size
  • Default font           size
  • Increase font size
Billion Dollar Backers for C3 PDF Print E-mail
Tuesday, 19 December 2006 12:51
Accentus C3 Technology is set to benefit significantly following its acquisition by Coller Capital. Coller completed a £40 million cash transaction on 30 September 2005 for 9 non-core portfolio businesses, including C3, as part of a planned disposal program by AEA Technology plc.
 

Latest News

03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest

Events

Respiratory Drug Delivery 2012
10 October 2011 08:57
article thumbnai